Read Time:8 Second
Viking Therapeutics Inc’s shares gained about 15% premarket on Thursday after the company signaled progress on an experimental obesity drug that could accelerate its development timeline.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
